# Tonix Pharmaceuticals Holding Corp. (TNXP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TNXP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 6.88M | $ -40.19M | $ -44.01M | $ 1.29M | $ 227.14M |
| 2025 | $ 13.42M | $ -126.99M | $ -107.74M | $ 1.31M | $ 245.15M |
| 2024 | $ 10.61M | $ -136.68M | $ -64.16M | $ 5.30M | $ 139.56M |
| 2023 | $ 8.40M | $ -126.14M | $ -118.83M | $ 9.81M | $ 105.53M |
| 2022 | $ 0 | $ -123.13M | $ -163.32M | $ 760.0K | $ 207.18M |
| 2021 | $ 0 | $ -109.70M | $ -131.78M | $ 956.0K | $ 218.72M |
| 2020 | $ 0 | $ -64.29M | $ -72.78M | $ 1.31M | $ 87.65M |
| 2019 | $ -645 | $ -40.13M | $ -34.46M | $ 358.0K | $ 9.42M |
| 2018 | $ 0 | $ -38.77M | $ -31.66M | $ 0 | $ 23.66M |
| 2017 | $ 0 | $ -28.46M | $ -25.77M | $ 0 | $ 24.62M |
| 2016 | $ 0 | $ -53.44M | $ -51.34M | $ 0 | $ 25.36M |
| 2015 | $ 0 | $ -67.47M | $ -59.88M | $ 0 | $ 40.26M |
| 2014 | $ 0 | $ -39.02M | $ -32.72M | $ 0 | $ 36.09M |
| 2013 | $ 0 | $ -15.48M | $ -12.13M | $ 280.0K | $ 6.51M |
| 2012 | $ 0 | $ -7.35M | $ -8.30M | $ 0 | $ 958.7K |
| 2011 | $ 0 | $ -5.10M | $ -3.87M | $ 2.08M | $ -2.45M |
| 2010 | $ 0 | $ -26.8K | $ -27.2K | $ 0 | $ -5.7K |
| 2009 | $ 0 | $ -46.7K | $ -42.2K | $ 0 | $ 12.0K |
| 2008 | $ 0 | $ -32.0K | $ -35.7K | $ 0 | $ 42.9K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.14 |
| Current Ratio | 6.99 |

## Other views

- [Metrics](https://sponda.capital/en/TNXP.md)
- [Charts](https://sponda.capital/en/TNXP/charts.md)
- [Compare](https://sponda.capital/en/TNXP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.